Company profilePharmaceutical#501 of 1,318 in Pakistan✓ No DRAP alerts

HEALTHTEK (PVT) LTD

Pharmaceutical company · 27 brands · 18 molecules

Ranked #188 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

27 registered products 27 pharmaceutical brands 18 distinct molecules 0 DRAP alerts

Company overview

27
registered products
27
pharmaceutical brands
18
distinct molecules
1
therapeutic classes
0
DRAP alerts

HEALTHTEK (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 27 product registrations across 18 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by HEALTHTEK

9 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

9
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20269

Top molecules by brand count

Sterile Water For Injection6 brands
Cefixime5 brands
Meropenem3 brands
Lidocaine2 brands
Piperacillin2 brands
Cefpirome1 brand
Gabapentin1 brand
Meropenem ...... 1 Gm1 brand
Meropenem ...... 500 Mg1 brand

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official28 products · Rs 5.34 – Rs 4,187.69
Median across source: Rs 294.28

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BOSCH PHARMACEUTICALS (PVT) LTD. holds 155 molecules not in this portfolio
AmikacinAmlodipineAmoxicillinAmoxicillin SodiumAmoxicillin …50Mg Clavulanic Acid 12.5 MgAmoxycillin
NEUTRO PHARMA (PVT) LTD. holds 125 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
Barrett Hodgson Pakistan (Private) Ltd. holds 173 molecules not in this portfolio
Acetylsalicylic AcidAmlodipineArtemetherAspirinAtorvastatinAzithromycin

Get the full profile for HEALTHTEK

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.